Dr Melanie Morris
BA(Hons) MSc PhD
Assistant Professor
EPH Taught Programme Director
After an Experimental Psychology degree at Oxford University, I trained at the Institute of Education and worked for several years in schools. In 2003 I undertook an MSc and then a PhD in Epidemiology at LSHTM. I then worked at UCL, returning to LSHTM in the Cancer Survival Group in 2012. Projects have included investigating the impact of screening on breast cancer survival differentials between ethnic and socio-economic groups, and investigating geographic variation in cancer outcomes in the UK and variations in treatment that may explain differences in cancer survival between England and the Nordic countries. I now work in the Health Services Research and Policy Department. I have studied the factors in different high-income health systems that may impact differences in cancer survival and I am now the lead epidemiologist for the National Prostate Cancer Audit.
Affiliations
Centres
Teaching
I am Taught Programme Director for the Faculty of Epidemiology and Population Health and was Deputy Exam Board chair for the Distance Learning MSc Epidemiology until January 2022.
Since starting my PhD, I have taught on the Distance Learning MSc Epidemiology, on the Fundamentals of Epidemiology module, spending four years as Module Organiser for the module Writing and Reviewing Scientific Papers. I still teach on Fundamentals of Epidemiology, running live web-based seminars, setting exams and marking assignments. I also teach on the intensive MSc Epidemiology and MSc Public Health co-organising Issues in Public Health until 2021.
I co-supervise a PhD student, jointly with Birkbeck as part of the Bloomsbury Studentship programme, working on decision-making around the receipt of chemotherapy in stage III colon cancer patients.
Research
I work in the Health Services Research and Policy department of the Faculty of Public Health and Policy. I worked on the International Cancer Benchmarking Partnership, aiming to establish which health system factors may explain some of the differences in cancer survival seen between countries with comparable health systems. I now work in the Clinical Effectiveness Unit, joint with the Royal College of Surgeons, as lead epidemiologist for the National Prostate Cancer Audit.
I am Deputy Director of the Centre for Global Chronic Conditions, with responsibility for the Cancer Interest Group, seminars and the student group.
Selected Publications
